VeriMomhypericum perforatum phytoplacenta culture extract est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification (ECHA Annex VI) or CIR/SCCS safety opinion specifically flagging 'Hypericum perforatum phytoplacenta culture extract' as a reproductive hazard; published literature on Hypericum shows pharmacological/systemic effects when taken orally but no confirmed teratogenicity that would trigger H360/H361 classification. Topical cosmetic use is expected to give low but measurable systemic exposure in adults (so exposure score 1). Sources considered: ECHA Annex VI (no harmonised classification for this ingredient), CIR (no specific adverse reproductive finding for cosmetic extracts of Hypericum), PubMed literature on Hypericum pharmacology.
Related ingredients
Frequently asked questions
- hypericum perforatum phytoplacenta culture extract est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification (ECHA Annex VI) or CIR/SCCS safety opinion specifically flagging 'Hypericum perforatum phytoplacenta culture extract' as a reproductive hazard; published literature on Hypericum shows pharmacological/systemic effects when taken orally but no confirmed teratogenicity that would trigger H360/H361 classification. Topical cosmetic use is expected to give low but measurable systemic exposure in adults (so exposure score 1). Sources considered: ECHA Annex VI (no harmonised classification for this ingredient), CIR (no specific adverse reproductive finding for cosmetic extracts of Hypericum), PubMed literature on Hypericum pharmacology.
- hypericum perforatum phytoplacenta culture extract est-il sûr pendant l'allaitement ?
- No authoritative safety assessment (CIR/SCCS/ECHA harmonised CLP) identifies this ingredient as a lactation/milk transfer reproductive hazard. Systemic absorption from topical use is expected to be low but not zero, so maternal exposure and potential minimal transfer to milk are possible but not demonstrated for this extract. Sources: PubMed literature on Hypericum systemic use (shows oral systemic effects rather than topical), CosIng/ECHA (no lactation-specific classification).
- hypericum perforatum phytoplacenta culture extract est-il sûr pour la peau de bébé ?
- No evidence of infant-specific reproductive or developmental toxicity for this ingredient in authoritative sources; therefore hazard and mechanism scores default to 0. Because infant skin has higher absorption and surface-area-to-weight ratio, exposure score is increased by +1 relative to adult topical use (adult e=1 → infant e=2). Note: photosensitizing constituents of Hypericum (hypericin) could be relevant for topical use on infants, but reproductive/endocrine effects in infants are not documented. Sources: general Hypericum literature (PubMed), CosIng/ECHA (no infant-specific safety findings).
- Comment VeriMom évalue-t-il hypericum perforatum phytoplacenta culture extract ?
- VeriMom évalue hypericum perforatum phytoplacenta culture extract à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à hypericum perforatum phytoplacenta culture extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à hypericum perforatum phytoplacenta culture extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.